Pharmacologic considerations in treating depression: a patient-centered approach.

Journal of managed care pharmacy : JMCP

Volumn 10, Issue 2 Suppl, 2004, Pages

  Ticknor, Christopher B ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

FEMALE; HUMAN; MAJOR DEPRESSION; MALE; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PATIENT CARE; REVIEW; SOMATOFORM DISORDER; SUICIDE; TREATMENT OUTCOME; UNITED STATES;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PATIENT-CENTERED CARE; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS; SUICIDE; TREATMENT OUTCOME; UNITED STATES;

EID: 2542427725     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)